SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CMPX

Compass Therapeutics Inc.
NASDAQHealth Care

Latest close: 0.86 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Reported purchase · Form 4Neil Lerner, Chief Accounting Officer · $18.4KOpen the filing ↗
  2. Sep 24, 2026Reported purchase · Form 4Neil Lerner, Chief Accounting Officer · $2.8KOpen the filing ↗
  3. Sep 22, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record33418 flagged findings
Reported transactions (Form 4)74since Jan 24, 2023 · and 14 other holdings
Corporate events (8-K)30since Jun 23, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 334)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Sep 22, 268-K ↗Current report · Communication to the market
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Vivo Opportunity Fund Holdings, L.P. · 4.0% · event on Jun 30, 26 · amendment
  • Aug 7, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 5.5% · event on Jun 30, 26
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Jul 1, 268-K ↗Current report · Communication to the market
  • Jun 23, 268-K ↗Current report · Bylaws or fiscal year change
  • Jun 11, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · BVF PARTNERS L P/IL · 4.3% · event on Mar 31, 26 · amendment
  • May 5, 2610-Q ↗Quarterly report
  • May 5, 268-K ↗Current report · Results
  • Insider transaction · 2 Form 4/A filingsshow all 2hide
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Apr 29, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 29, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 27, 268-K ↗Current report · Communication to the market · Other events
  • Mar 5, 2610-K ↗Annual report
  • Mar 5, 268-K ↗Current report · Results
  • Feb 13, 26SCHEDULE 13G/A ↗Passive stake · Blackstone Alternative Asset Management Associates LLC · 3.4% · event on Dec 31, 25 · amendment
  • Feb 10, 26Form 4 ↗Insider transaction
  • Jan 21, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.2% · event on Dec 31, 25

334 filings on record, the oldest from Jul 30, 18.

Listing the 25 most recent filings of the 334 on record.

8-Ks, explained

Structure17Governance18
  • Aug 13, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance7 senior executive changes2022 – 2024show all 7hide
    • Dec 10, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 28, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 9, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 24, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 24, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 10, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 29, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 2, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Aug 19, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 1, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2021 – 2022show all 3hide
    • Apr 26, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 25, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 21, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2021show all 3hide
    • Nov 3, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jun 30, 21StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗
    • May 13, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 19, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Dec 17, 20StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Sep 15, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 31, 20StructureCompleted an acquisition or disposal8-K/A 2.01 ↗
  • Jun 23, 20StructureEntered a material agreement+8 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC8.9%Aug 13, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Commander Aggregator, LP4.5%Aug 14, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • TANG CAPITAL MANAGEMENT, LLC10.0%Sep 30, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • RTW Investments, LP9.9%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Suvretta Capital Management, LLC8.2%Aug 13, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • STATE STREET CORPORATION5.5%Jun 30, 26SCHEDULE 13G ↗
  • BlackRock, Inc.5.2%Dec 31, 25SCHEDULE 13G ↗1 earlier filing
show 4 more holdershide
  • BVF PARTNERS L P/IL4.3%Mar 31, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • MPM BioImpact LLC4.1%Jun 30, 25SCHEDULE 13G/A ↗
  • Vivo Opportunity Fund Holdings, L.P.4.0%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Blackstone Alternative Asset Management Associates LLC3.4%Dec 31, 25SCHEDULE 13G/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 1, 26Buy$18KNeil LernerChief Accounting Officer↗
  • Sep 24, 26Buy$3KNeil LernerChief Accounting Officer↗
  • Apr 29, 26Buy$47KJonathan AndermanGeneral Counsel↗
  • Apr 29, 26Buy$28KNeil LernerChief Accounting Officer↗
  • May 27, 25Buy$21KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Apr 9, 25Sell$5.7MORBIMED ADVISORS LLC↗
  • Apr 9, 25Sell$5.7MCARL L GORDON↗
  • Apr 7, 25Buy$28KNeil LernerCHIEF ACCOUNTING OFFICER↗
  • Apr 7, 25Buy$31KJonathan AndermanGen Counsel & Corporate Sec↗
  • Mar 10, 23Buy$34KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Feb 27, 23Buy$80KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Feb 15, 23Buy$77KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗

There are 2 more transactions in this stretch.

Stock compensation, tax and giftsshow the 20 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Apr 29, 26Compensation$28KNeil LernerChief Accounting Officer↗
  • Apr 29, 26Compensation$47KJonathan AndermanGeneral Counsel↗
  • Feb 8, 26Tax$239KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Jan 9, 26Tax$250KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Jan 2, 26Compensation$776KJonathan AndermanGeneral Counsel↗
  • Jan 2, 26Compensation$323KNeil LernerChief Accounting Officer↗
  • Jan 2, 26Compensation$1.3MThomas J. SchuetzCEO↗
  • Jan 2, 26Compensation$646KBarry ShinCFO↗
  • Nov 16, 25Tax$213KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Feb 8, 25Tax$146KThomas J. SchuetzCEO↗
  • Jan 9, 25Tax$108KThomas J. SchuetzCEO↗
  • Dec 9, 24Compensation$660KBarry ShinCFO↗
  • Feb 8, 24Tax$65KThomas J. SchuetzPRESIDENT↗
  • Feb 8, 24Tax$71KVered Bisker-LeibCHIEF EXECUTIVE OFFICER↗
  • Jan 9, 24Compensation$1.2MThomas J. SchuetzPresident of R&D↗
  • Jan 9, 24Compensation$3.4MVered Bisker-LeibChief Executive Officer↗
  • Nov 17, 23Tax$66KThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗
  • Nov 17, 23Tax$97KVered Bisker-LeibChief Operating Officer↗
  • Feb 8, 23Compensationamount n/aVered Bisker-LeibChief Operating Officer↗
  • Feb 8, 23Compensationamount n/aThomas J. SchuetzCHIEF EXECUTIVE OFFICER↗

The full record holds 34 transactions and goes back to Jan 24, 23.

Its sector and its market

Compass Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Compass Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Compass Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
334 documents on file, from Jul 30, 2018 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Compass Therapeutics Inc. (CMPX): stock price history, insider trades and SEC filings — HornScout